Royal DSM, a global science-based company active in Health, Nutrition & Bioscience, will showcase its latest innovations at Vitafoods Europe 2022, May 2-13, 2022, in Geneva, Switzerland.
Those purpose-led solutions target immunity, gut, brain health and more. At Booth #F80, visitors can discover DSM’s science-backed and sustainable market-ready solutions that help to streamline product development; enabling customers to get to market faster with health benefit-driven solutions. Plus, visitors can explore DSM’s broad ingredient portfolio for the maternal nutrition market through a series of new concepts.
With immunity remaining a top consumer health concern in 2022, DSM will introduce ampli-D®, as it showcases its extensive portfolio of solutions and capabilities as an end-to-end partner. Currently pending approval from the European Commission as a novel food and source of vitamin D, ampli-D® is a bioavailable source of the biologically active metabolite of vitamin D and will be available as a market-ready solution. Through its more efficient action, ampli-D® will enable customers to support the health of the 88% of individuals globally reported to have suboptimal vitamin D levels.
Another ingredient attracting attention in the health and nutrition market is cannabidiol (CBD). CBD is set to shake up the dietary supplements category, powered by rising consumer interest in its potential benefits across a number of areas related to brain health, including stress, mood and sleep. At the show, visitors can learn more about DSM’s new customized premix and market-ready solutions for CBD, which are designed to enable customers to enter the market with speed and confidence as soon as the ingredient is authorized in the European Union.
Also in the spotlight will be DSM’s gut health expertise. Visitors to Vitafoods Europe can explore how the company continues to support cutting-edge innovation in the gut space, including how it is helping customers navigate the developing science in the HMO market.
On booth F80, DSM will present its market-ready life’s™OMEGA and Sprinkle It solutions too. A concentrated algal-derived omega-3 in its natural triglyceride form, life’s™OMEGA delivers the health benefits of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in one single, quality source.
Visitors can discover more about life’s™OMEGA and how it is creating exciting opportunities for brands to attract a new generation of health-conscious consumers seeking more sustainable ways to support a broad range of health benefits. Sprinkle It is another market-ready solution, specially designed to deliver vitamins and minerals in a convenient granule format, that consumers can take as is or mixed with food. Bringing its world-class premix capabilities, DSM is able to help customers tailor the solution to target specific health needs.
In addition, early life nutrition experts will be on stand to discuss and showcase DSM’s maternal nutrition capabilities, and how it supports product development from conception to lactation. At the show, new concepts including hero ingredients, such as life’sDHA® and Metafolin® will be presented. Sourced from algal oil, life’sDHA® is a sustainable, plant-based alternative to fish oil, proven to support infant brain and cognitive development and reduce the risk of preterm birth, whereas Metafolin® is a readily bioavailable form of folate that is easily absorbed by the body. Finally, visitors will also get the opportunity to meet with Hologram Sciences to explore partnerships related to personalized nutrition.
DSM – Bright Science. Brighter Living.™
Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sus-tainable Living. DSM’s purpose is to create brighter lives for all. DSM addresses with its products and solutions some of the world’s biggest challenges while simultaneously creating economic, envi-ronmental and societal value for all its stakeholders – customers, employees, shareholders, and society at large. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivi-ty. DSM and its associated companies deliver annual net sales of about €10 billion with approxi-mately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam.
www.dsm.com
